These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 410685)

  • 1. The biotransformation of phenylbutazone (Butazolidin).
    Faigle JW; Dieterle W
    J Int Med Res; 1977; 5 Suppl 2():2-14. PubMed ID: 410685
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolism of phenylbutazone in man.
    Dieterle W; Faigle JW; Früh F; Mory H; Theoblad W; Alt KO; Richter WJ
    Arzneimittelforschung; 1976 Apr; 26(4):572-7. PubMed ID: 782467
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolic disposition of isoxicam in man, monkey, dog, and rat.
    Borondy PE; Michniewicz BM
    Drug Metab Dispos; 1984; 12(4):444-51. PubMed ID: 6148211
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antilipidemic drugs. Part 4: The metabolic fate of the hypolipidemic agent isopropyl-[4'-(p-chlorobenzoyl)-2-phenoxy-2-methyl]-protionate (LF 178) in rats, dog and man.
    Brodie RR; Chasseaud LF; Elson FF; Franklin ER; Taylor T
    Arzneimittelforschung; 1976; 26(5):896-901. PubMed ID: 989365
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolism of labetalol by animals and man.
    Martin LE; Hopkins R; Bland R
    Br J Clin Pharmacol; 1976 Aug; 3(4 Suppl 3):695-710. PubMed ID: 990152
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical pharmacokinetics of phenylbutazone.
    Aarbakke J
    Clin Pharmacokinet; 1978; 3(5):369-80. PubMed ID: 359213
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preclinical pharmacokinetics and metabolism of 6-(4-(2,5-difluorophenyl)oxazol-5-yl)-3-isopropyl-[1,2,4]-triazolo[4,3-a]pyridine, a novel and selective p38alpha inhibitor: identification of an active metabolite in preclinical species and human liver microsomes.
    Kalgutkar AS; Hatch HL; Kosea F; Nguyen HT; Choo EF; McClure KF; Taylor TJ; Henne KR; Kuperman AV; Dombroski MA; Letavic MA
    Biopharm Drug Dispos; 2006 Nov; 27(8):371-86. PubMed ID: 16944451
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolism and excretion of RWJ-333369 [1,2-ethanediol, 1-(2-chlorophenyl)-, 2-carbamate, (S)-] in mice, rats, rabbits, and dogs.
    Mamidi RN; Mannens G; Annaert P; Hendrickx J; Goris I; Bockx M; Janssen CG; Kao M; Kelley MF; Meuldermans W
    Drug Metab Dispos; 2007 Apr; 35(4):566-75. PubMed ID: 17220243
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NTP Toxicology and Carcinogenesis Studies of Phenylbutazone (CAS No. 50-33-9) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1990 Mar; 367():1-205. PubMed ID: 12692637
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Studies on pharmacokinetics and biotransformation of reproterol in animal and man (author's transl)].
    Niebch G; Obermeier K; Vergin H; Thiemer K
    Arzneimittelforschung; 1977; 27(12):37-45. PubMed ID: 576829
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Disposition of the dipeptidyl peptidase 4 inhibitor sitagliptin in rats and dogs.
    Beconi MG; Reed JR; Teffera Y; Xia YQ; Kochansky CJ; Liu DQ; Xu S; Elmore CS; Ciccotto S; Hora DF; Stearns RA; Vincent SH
    Drug Metab Dispos; 2007 Apr; 35(4):525-32. PubMed ID: 17220241
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolic fate of premazepam, a new anti-anxiety drug, in the rat and the dog.
    Assandri A; Barone D; Ferrari P; Perazzi A; Ripamonti A; Tuan G; Zerilli LF
    Drug Metab Dispos; 1984; 12(2):257-63. PubMed ID: 6144494
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biotransformation of bromperidol in rat, dog, and man.
    Wong FA; Bateman CP; Shaw CJ; Patrick JE
    Drug Metab Dispos; 1983; 11(4):301-7. PubMed ID: 6137334
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics and metabolism of the new thromboxane A2 receptor antagonist ramatroban in animals. 1st communication: absorption, concentrations in plasma, metabolism, and excretion after single administration to rats and dogs.
    Boberg M; Ahr HJ; Beckermann B; Bühner K; Siefert HM; Steinke W; Wünsche C; Hirayama M
    Arzneimittelforschung; 1997 Aug; 47(8):928-38. PubMed ID: 9296279
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of low estrogen combination oral contraceptive on metabolism of aspirin and phenylbutazone.
    Gupta KC; Joshi JV; Hazari K; Pohujani SM; Satoskar RS
    Int J Clin Pharmacol Ther Toxicol; 1982 Nov; 20(11):511-3. PubMed ID: 7174153
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Biotransformation of tramadol in man and animal (author's transl)].
    Lintz W; Erlaçin S; Frankus E; Uragg H
    Arzneimittelforschung; 1981; 31(11):1932-43. PubMed ID: 7198474
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The disposition of radioactivity after administration of the anthelminthic methyl-14C-5-cyclopropylcarbonyl-2-benzimidazole carbamate (ciclobendazole) to rats and dogs.
    Brodie RR; Mayo BC; Chasseaud LF; Hawkins DR
    Arzneimittelforschung; 1977; 27(3):593-8. PubMed ID: 577426
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [AR-L 115 BS, comparison of human metabolite pattern and biotransformation with other species].
    Roth W; Prox A; Reuter A; Schmid J; Zimmer A; Zipp H
    Arzneimittelforschung; 1981; 31(1a):232-5. PubMed ID: 7195228
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Ambroxol, comparative studies of pharmacokinetics and biotransformation in rat, rabbit, dog and man (author's transl)].
    Hammer R; Bozler G; Jauch R; Koss FW; Hadamovsky H
    Arzneimittelforschung; 1978; 28(5a):899-903. PubMed ID: 581988
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro and in vivo metabolism of desogestrel in several species.
    Verhoeven CH; Krebbers SF; Wagenaars GN; Vos RM
    Drug Metab Dispos; 1998 Sep; 26(9):927-36. PubMed ID: 9733673
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.